# Citrulline and Arginase Activity in Severe Sepsis and Septic Shock

> **NCT03837730** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 118 (actual)

## Conditions studied

- Intensive Care Units
- Infection
- Biomarkers
- Sepsis
- Septic Shock

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03837730
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-28
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03837730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03837730, "Citrulline and Arginase Activity in Severe Sepsis and Septic Shock". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03837730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*